October 11 2024 - Gilead gives up on $15M MASH bet with Yuhan after mulling preclinical data

October 11 2024 - Gilead gives up on $15M MASH bet with Yuhan after mulling preclinical data

Gilead gives up on $15M MASH bet with Yuhan after mulling preclinical data
Teva hands over $450M to resolve kickback lawsuits involving MS drug Copaxone and generics
Roche gets FDA green light for breast cancer drug Itovebi
Sanofi in talks to sell stake in consumer health spinout
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*
image: